# National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Organization · id `cardio:org-national-medical-research-center-for-cardiology-ministry-of-62fee0` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=National+Medical+Research+Center+for+Cardiology%2C+Ministry+of+Health+of+Russian+Federation>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.

## Technical summary

Sponsor class other government. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
- Sponsor class: OTHER\_GOV

## Connected pages

- Sponsors: Cardiac Contractility Modulation in Patients With Chronic Heart Failure and the Various Forms of Atrial Fibrillation (`cardio:ct-nct05550792`)
- Sponsors: A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon®, Tablets, 1 mg for Long-term Use to Prevent Recurrence of Atrial Fibrillation/Flutter After Terminating Its Persistent Form (`cardio:ct-nct06540352`)
- Sponsors: Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension (`cardio:ct-nct06683040`)
- Sponsors: Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI (`cardio:ct-nct07149714`)
- Sponsors: ULTRAsound-assisted Catheter-guided Thrombolysis for Intermediate-high Risk Patients With PE (`cardio:ct-nct07452991`)
- Sponsors: Reperfusion Approach in Predicted In-hospital Delay for Primary PCI in STEMI (`cardio:ct-nct07641231`)

## Provenance

Content hash: e90393e951edbce46fe3ed692d20de1610ff8ed2d543aabb4bad8cf2b7d2468f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
